Delveinsight Business Research LLP Currently, there are no specific therapeutic cures for Facioscapulohumeral Muscular Dystrophy (FSHD). But in 2010, the standard of care and management of FSHD were discussed, and a census was agreed on at the 171st ENMC International Workshop. The main treatment strategies are divided upon the different aspects of the muscle systems […]
Delveinsight Business Research LLP As per DelveInsight, the Tendinopathy Therapeutics Market is expected to grow in the coming years owing to the rising cases worldwide. A better disease understanding and advancement in the therapeutic segment are also anticipated to boost the market growth. The current emerging landscape for Tendinopathy is limited, mainly comprising Phase II […]
Delveinsight Business Research LLP As per DelveInsight, the Medulloblastoma therapeutics market size shall grow in the coming years due to the advent of deep sequencing gene technology that has provided invaluable clues to the molecular makeup of this tumour. The rising awareness among people regarding cancer, the launch of emerging therapies, and the active participation […]
In 2021, Samsung BioLogics (South Korea) entered into a Development and Manufacturing Agreement with Kineta (US) for Anti-VISTA Antibody Immunotherapy. The Pharmaceutical Contract Development and Manufacturing Market is projected to reach USD 171.3 billion by 2026 from USD 120.6 billion in 2021, at a CAGR of 7.3% between 2021 and 2026. Patent expiry and increasing […]
Delveinsight Business Research LLP The Chronic Spontaneous Urticaria Therapeutics Market is expected to grow in the coming years owing to the rising awareness of the disease, improved management, and better outcomes with the launch of emerging therapies. The ongoing Research and Development (R&D) activities and the active participation of the global pharma and biotech giants […]
Delveinsight Business Research LLP As per DelveInsight, the Pemphigus Vulgaris therapeutics market is expected to grow by factors like the increase in the prevalent pool, rising awareness among patients, the recent approval of MabThera/Rituxan, and the expected entry of novel emerging therapies in the market. “Pemphigus Vulgaris Pipeline Insight, 2022” report by DelveInsight outlines comprehensive […]
Delveinsight Business Research LLP As per DelveInsight, the Vitiligo Therapeutics Market is expected to grow in the coming years owing to the increase in the prevalent cases, the better understanding of the disease, and the launch of emerging therapies. Globally, several key companies are actively working in the Vitiligo Market. The launch of the emerging […]
Delveinsight Business Research LLP Faecal Incontinence is a challenging condition of diverse etiology & devastating psychosocial impact. Etiologic factors include traumatic, neurologic, congenital, & iatrogenic. Depending on the etiology, Faecal Incontinence may have associated symptoms which need to be actively checked with the patient, such as urinary incontinence, vaginal bulging, prolapse, rectovaginal fistula, and altered […]
Delveinsight Business Research LLP The Alopecia market size is expected to increase in the coming years owing to the rise in the prevalence of alopecia and the expected launch of emerging therapies. The ongoing Research and Development (R&D) activities and the active participation of the global pharma and biotech giants in the therapeutic segment will […]
Delveinsight Business Research LLP Peripheral Nerve Injuries market size is anticipated to increase in the coming years owing to the rising population in the 7MM. The availability of technologically advanced nerve repair and regeneration products and the expected launch of emerging therapies will also boost the Peripheral Nerve Injuries Market Growth. DelveInsight’s “Peripheral Nerve Injuries […]
